David Mitchell

David C.
Mitchell formerly worked at Biogen, Inc., as Director-Regulatory Affairs from 2000 to 2004, CancerVax Corp., as Senior Director-Regulatory Affairs & Quality, Reata Pharmaceuticals, Inc., as Director-Regulatory Affairs & Quality Assurance, The Upjohn Co., as Principal, Novalar Pharmaceuticals, Inc., as VP-Regulatory Affairs & Quality Assurance, Spyre Therapeutics, Inc., as Vice President-Regulatory Affairs & Quality, Aquinox Pharmaceuticals, Inc., as VP-Global Regulatory Affairs & Quality Assurance from 2014 to 2017, Actelion Pharmaceuticals US, Inc., as Principal, Sumitovant Biopharma, Inc., as Senior Vice President & Head-Regulatory Affairs, and Verastem, Inc., as Senior Vice President & Head-Regulatory Affairs from 2023 to 2024.
Mr. Mitchell received his graduate degree from The Johns Hopkins University and undergraduate degree from Mississippi College.